Valve-In-Valve Risk Assessment Systems and Methods
Summary
USPTO published patent application US20260096852A1 by Spencer et al. disclosing systems and methods for evaluating risks of valve-in-valve cardiac procedures where a replacement transcatheter aortic valve is deployed within an existing bioprosthetic valve. The invention involves receiving patient anatomy images, obtaining anatomical measurements, comparing against predetermined benchmarks, and evaluating procedural risks.
What changed
USPTO published patent application US20260096852A1 titled 'Systems and Methods for Assessing Valve-In-Valve Risks' by inventors Spencer, Tadros, Garde, and Popma. The application covers methods for evaluating proposed valve-in-valve procedures by selecting predetermined benchmark measurements of valve combinations, receiving patient anatomy images, obtaining anatomical measurements from the images, and evaluating risks based on comparisons between benchmark and anatomical measurements.
Medical device manufacturers developing transcatheter valve products and healthcare providers performing valve-in-valve procedures should monitor this patent's progression. While patent applications do not create immediate compliance obligations, they establish priority dates and define intellectual property that may affect future product development and clinical procedure approaches.
What to do next
- Monitor for updates
- Review for potential licensing interests
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Systems and Methods for Assessing Valve-In-Valve Risks
Application US20260096852A1 Kind: A1 Apr 09, 2026
Inventors
Julianne H. SPENCER, Hatem TADROS, Kshitija P. GARDE, Jeffrey J. POPMA
Abstract
Systems and methods for evaluating a proposed valve-in-valve procedure for a patient in which a replacement transcatheter aortic valve will be deployed within a first bioprosthetic aortic valve. The methods include selecting predetermined benchmark measurements of a valve-in-valve combination. Images of anatomy of the patient are received. Anatomical measurements of the first bioprosthetic valve are obtained from the received images. The predetermined benchmark measurements and the anatomical measurements are reviewed. Based, at least in part, upon the review, risks of a valve-in-valve procedure for the patient are evaluated. The methods of the present disclosure can be used on baseline scans of a patient without a first bioprosthetic valve implanted; under these circumstances, dimensions of the first valve are determined by benchmark measurements. Where methods of the present disclosure are used on post-first implant scans, then the dimensions of the first valve are determined from the post-implant scans.
CPC Classifications
A61B 34/10 G06T 7/0012 G06T 7/62 G16H 50/30 A61B 2034/105 A61B 2034/108 A61F 2/2418 G06T 2207/30048 G06T 2207/30052 G06T 2207/30104
Filing Date
2023-10-05
Application No.
19114488
Related changes
Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.